Extracellular vesicle protein CD14 relates to common carotid intima-media thickness in eight year old children

Atherosclerosis

Volumn 236, Issue 2, 2014, Pages 270-276

  Eikendal, Anouk L M ^a,c   den Ruijter, Hester M ^a,c   Uiterwaal, Cuno S P M ^a,c   Pasterkamp, Gerard ^a,c   Hoefer, Imo E ^a,c   de Kleijn, Dominique P V ^a,b,c   Schoneveld, Arjan H ^a,c   Leiner, Tim ^a,c   Bots, Michiel L ^a,c   Visseren, Frank L J ^a,c   Evelein, Annemieke M V ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NONE   (Netherlands)

Author keywords

Atherosclerosis; Children; Extracellular vesicle; Inflammation; Protein; Vascular alterations

Indexed keywords

CD14 ANTIGEN; CYSTATIN C; LIPID; SERINE PROTEINASE INHIBITOR; SERPIN F2; UNCLASSIFIED DRUG; ALPHA 2 ANTIPLASMIN; CST3 PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL; INSULIN;

ANTHROPOMETRY; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHILD; COHORT ANALYSIS; ECHOGRAPHY; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; SCHOOL CHILD; YOUNG MODULUS; ABNORMAL RESPIRATORY SOUND; ANALYSIS; ARTERIAL STIFFNESS; ATHEROSCLEROSIS; BLOOD; CHEMISTRY; COMMON CAROTID ARTERY; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; MEMBRANE MICROPARTICLE; NETHERLANDS; ONSET AGE; PATHOLOGY; PROSPECTIVE STUDY; VASCULITIS;

AGE OF ONSET; ALPHA-2-ANTIPLASMIN; ANTHROPOMETRY; ANTIGENS, CD14; ATHEROSCLEROSIS; BLOOD GLUCOSE; CAROTID ARTERY, COMMON; CAROTID INTIMA-MEDIA THICKNESS; CELL-DERIVED MICROPARTICLES; CHILD; CYSTATIN C; ELASTIC MODULUS; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; NETHERLANDS; PROSPECTIVE STUDIES; RESPIRATORY SOUNDS; VASCULAR STIFFNESS; VASCULITIS;

EID: 84907072332     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.07.018     Document Type: Article

References (44)

1. Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012, 380:2095-2128.
2. Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY study. Pathobiological determinants of atherosclerosis in youth (PDAY) research group. Arterioscler Thromb 1993, 13:1291-1298.
3. Berenson G.S., Srinivasan S.R., Bao W., Newman W.P., Tracy R.E., Wattigney W.A. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 1998, 338:1650-1656. [The Bogalusa heart study].
4. Davis P.H., Dawson J.D., Riley W.A., Lauer R.M. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine study. Circulation 2001, 104:2815-2819.
5. Li S., Chen W., Srinivasan S.R., Bond M.G., Tang R., Urbina E.M., et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa heart study. JAMA 2003, 290:2271-2276.
6. Raitakari O.T., Juonala M., Kahonen M., Taittonen L., Laitinen T., Maki-Torkko N., et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the cardiovascular risk in young Finns study. JAMA 2003, 290:2277-2283.
7. Juonala M., Magnussen C.G., Venn A., Dwyer T., Burns T.L., Davis P.H., et al. Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: the cardiovascular risk in young Finns study, the childhood determinants of adult health study, the Bogalusa heart study, and the Muscatine study for the international childhood cardiovascular cohort (i3c) consortium. Circulation 2010, 122:2514-2520.
8. Oikonen M., Laitinen T.T., Magnussen C.G., Steinberger J., Sinaiko A.R., Dwyer T., et al. Ideal cardiovascular health in young adult populations from the United States, Finland, and Australia and its association with cIMT: The international childhood cardiovascular cohort consortium. J Am Heart Assoc 2013, 2:e000244.
9. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115:459-467.
10. Robertson C.M., Gerry F., Fowkes R., Price J.F. Carotid intima-media thickness and the prediction of vascular events. Vasc Med 2012, 17:239-248.
11. Urbina E.M., Kimball T.R., McCoy C.E., Khoury P.R., Daniels S.R., Dolan L.M. Youth with obesity and obesity-related type 2 diabetes mellitus demonstrate abnormalities in carotid structure and function. Circulation 2009, 119:2913-2919.
12. Evelein A.M., Visseren F.L., van der Ent C.K., Grobbee D.E., Uiterwaal C.S. Excess early postnatal weight gain leads to thicker and stiffer arteries in young children. J Clin Endocrinol Metab 2013, 98:794-801.
13. Geerts C.C., Evelein A.M., Bots M.L., van der Ent C.K., Grobbee D.E., Uiterwaal C.S. Body fat distribution and early arterial changes in healthy 5-year-old children. Ann Med 2012, 44:350-359.
14. Woo K.S., Chook P., Yu C.W., Sung R.Y., Qiao M., Leung S.S., et al. Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation 2004, 109:1981-1986.
15. Wunsch R., de Sousa G., Toschke A.M., Reinehr T. Intima-media thickness in obese children before and after weight loss. Pediatrics 2006, 118:2334-2340.
16. Rautou P.E., Vion A.C., Amabile N., Chironi G., Simon A., Tedgui A., et al. Microparticles, vascular function, and atherothrombosis. Circ Res 2011, 109:593-606.
17. Pasterkamp G., de Kleijn D. Microparticles, debris that hurts. J Am Coll Cardiol 2008, 52:1312-1313.
18. VanWijk M.J., VanBavel E., Sturk A., Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003, 59:277-287.
19. Kanhai D.A., Visseren F.L., van der Graaf Y., Schoneveld A.H., Catanzariti L.M., Timmers L., et al. Microvesicle protein levels are associated with increased risk for future vascular events and mortality in patients with clinically manifest vascular disease. Int J Cardiol 2013, 168:2358-2363.
20. Verhoeven B.A., Velema E., Schoneveld A.H., de Vries J.P., de Bruin P., Seldenrijk C.A., et al. Athero-express: differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design. Eur J Epidemiol 2004, 19:1127-1133.
21. Vrijenhoek J.E., Pasterkamp G., Moll F.L., Borst G.J., Bots M.L., Catanzariti L., et al. Extracellular vesicle-derived CD14 is independently associated with the extent of cardiovascular disease burden in patients with manifest vascular disease. Eur J Prev Cardiol 2014, 1-7.
22. Katier N., Uiterwaal C.S., de Jong B.M., Kimpen J.L., Verheij T.J., Grobbee D.E., et al. The Wheezing Illnesses Study Leidsche Rijn (whistler): rationale and design. Eur J Epidemiol 2004, 19:895-903.
23. Brands P.J., Hoeks A.P., Willigers J., Willekes C., Reneman R.S. An integrated system for the non-invasive assessment of vessel wall and hemodynamic properties of large arteries by means of ultrasound. Eur J Ultrasound 1999, 9:257-266.
24. Paini A., Boutouyrie P., Calvet D., Zidi M., Agabiti-Rosei E., Laurent S. Multiaxial mechanical characteristics of carotid plaque: analysis by multiarray echotracking system. Stroke: J Cereb Circul 2007, 38:117-123.
25. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
26. Kurtoglu S., Hatipoglu N., Mazicioglu M., Kendirici M., Keskin M., Kondolot M. Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods. J Clin Res Pediatr Endocrinol 2010, 2:100-106.
27. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
28. Palmerini T., Coller B.S., Cervi V., Tomasi L., Marzocchi A., Marrozzini C., et al. Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system. J Am Coll Cardiol 2004, 44:1570-1577.
29. Leatham E.W., Bath P.M., Tooze J.A., Camm A.J. Increased monocyte tissue factor expression in coronary disease. Br Heart J 1995, 73:10-13.
30. Dharnidharka V.R., Kwon C., Stevens G. Serum cystatin c is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002, 40:221-226.
31. Shlipak M.G., Katz R., Sarnak M.J., Fried L.F., Newman A.B., Stehman-Breen C., et al. Cystatin c and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 2006, 145:237-246.
32. Shlipak M.G., Sarnak M.J., Katz R., Fried L.F., Seliger S.L., Newman A.B., et al. Cystatin c and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005, 352:2049-2060.
33. Kranendonk M.E., de Kleijn D.P., Kalkhoven E., Kanhai D.A., Uiterwaal C.S., van der Graaf Y., et al. Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease. Cardiovasc Diabetol 2014, 13:37.
34. Kim J., Bhattacharjee R., Kheirandish-Gozal L., Spruyt K., Gozal D. Circulating microparticles in children with sleep disordered breathing. Chest 2011, 140:408-417.
35. Dursun I., Poyrazoglu H.M., Gunduz Z., Ulger H., Yykylmaz A., Dusunsel R., et al. The relationship between circulating endothelial microparticles and arterial stiffness and atherosclerosis in children with chronic kidney disease. Nephrol Dial Transpl 2009, 24:2511-2518.
36. Gunduz Z., Dursun I., Tulpar S., Bastug F., Baykan A., Yikilmaz A., et al. Increased endothelial microparticles in obese and overweight children. J Pediatr Endocrinol Metab 2012, 25:1111-1117.
37. Schipper H.S., Nuboer R., Prop S., van den Ham H.J., de Boer F.K., Kesmir C., et al. Systemic inflammation in childhood obesity: circulating inflammatory mediators and activated CD14++ monocytes. Diabetologia 2012, 55:2800-2810.
38. Dubern B., Lafarge J.C., Fellahi S., Naour N., Copin N., Bastard J.P., et al. Relevance of increased serum cystatin c to vascular alterations in obese children. Pediatr Obes 2012, 7:374-381.
39. Ciccone M.M., Scicchitano P., Salerno C., Gesualdo M., Fornarelli F., Zito A., et al. Aorta structural alterations in term neonates: the role of birth and maternal characteristics. BioMed Res Int 2013, 2013:459168.
40. Ciccone M.M., Bilianou E., Balbarini A., Gesualdo M., Ghiadoni L., Metra M., et al. Task force on: 'Early markers of atherosclerosis: influence of age and sex'. J Cardiovasc Med Hagerst 2013, 14:757-766.
41. Ciccone M.M., Miniello V., Marchioli R., Scicchitano P., Cortese F., Palumbo V., et al. Morphological and functional vascular changes induced by childhood obesity. Eur J Cardiovasc Prev Rehabil: Off J Eur Soc Cardiol Work Groups Epidemiol Prev Cardiac Rehabil Exerc Physiol 2011, 18:831-835.
42. Ciccone M.M., Favale S., Bhuva A., Scicchitano P., Caragnano V., Lavopa C., et al. Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome. Vasc Health Risk Manag 2009, 5:561-566.
43. Stein J.H., Korcarz C.E., Hurst R.T., Lonn E., Kendall C.B., Mohler E.R., et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American society of echocardiography carotid intima-media thickness task force. Endorsed by the society for vascular medicine. J Am Soc Echocardiogr: Off Publ Am Soc Echocardiogr 2008, 21:93-111. (quiz 189-190).
44. Naghavi M., Falk E., Hecht H.S., Jamieson M.J., Kaul S., Berman D., et al. From vulnerable plaque to vulnerable patient - part III: executive summary of the screening for heart attack prevention and education (shape) task force report. Am J Cardiol 2006, 98:2H-15H.